HCPCS Level II
J9317
Injection, sacituzumab govitecan-hziy, 2.5 mg
Codes near J9317
These sit next to J9317 in the CMS Level II file. All J codes
- J9312Injection, rituximab, 10 mg
- J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- J9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
- J9315Injection, romidepsin, 1 mg
- J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9318Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319Injection, romidepsin, lyophilized, 0.1 mg
- J9320Injection, streptozocin, 1 gram
- J9321Injection, epcoritamab-bysp, 0.16 mg
- J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 55135-0132-01 | Trodelvy | Immunomedics, Inc. | 72 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.